Noriaki Endo

1.6k total citations
22 papers, 1.4k citations indexed

About

Noriaki Endo is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Noriaki Endo has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Noriaki Endo's work include Chemokine receptors and signaling (7 papers), Alzheimer's disease research and treatments (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Noriaki Endo is often cited by papers focused on Chemokine receptors and signaling (7 papers), Alzheimer's disease research and treatments (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Noriaki Endo collaborates with scholars based in Japan, United States and United Kingdom. Noriaki Endo's co-authors include Satoshi Asano, Takami Tomiyama, Ken-ichiro Kataoka, Hideshi Kaneko, Kohei Ota, David A. Hafler, Howard L. Weiner, Kai W. Wucherpfennig, Anthony Rosenzweig and Jonathan G. Seidman and has published in prestigious journals such as Science, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

Noriaki Endo

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noriaki Endo Japan 17 484 463 443 262 190 22 1.4k
Rodger A. Allen United States 26 407 0.8× 1.2k 2.5× 1.0k 2.3× 219 0.8× 91 0.5× 43 2.3k
Stefani N. Thomas United States 24 487 1.0× 1.4k 3.0× 221 0.5× 192 0.7× 96 0.5× 61 2.1k
Peter Olofsson Sweden 22 217 0.4× 724 1.6× 1.3k 3.0× 417 1.6× 187 1.0× 50 2.4k
Kaoru Saegusa Japan 12 401 0.8× 1.2k 2.6× 606 1.4× 125 0.5× 62 0.3× 15 2.5k
Heidi A. Zürcher-Neely United States 18 563 1.2× 1.0k 2.2× 140 0.3× 209 0.8× 71 0.4× 22 1.6k
Richard D. Bagshaw Canada 23 559 1.2× 1.2k 2.6× 219 0.5× 196 0.7× 70 0.4× 32 2.1k
James R. Burke United States 24 126 0.3× 1.1k 2.4× 738 1.7× 538 2.1× 47 0.2× 55 2.3k
Sunanda G. Dastidar India 21 219 0.5× 618 1.3× 190 0.4× 181 0.7× 43 0.2× 56 1.4k
François G. Gervais Canada 21 779 1.6× 1.5k 3.3× 599 1.4× 327 1.2× 51 0.3× 30 2.8k
David J. Shuster United States 19 75 0.2× 525 1.1× 749 1.7× 297 1.1× 109 0.6× 29 1.6k

Countries citing papers authored by Noriaki Endo

Since Specialization
Citations

This map shows the geographic impact of Noriaki Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriaki Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriaki Endo more than expected).

Fields of papers citing papers by Noriaki Endo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noriaki Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriaki Endo. The network helps show where Noriaki Endo may publish in the future.

Co-authorship network of co-authors of Noriaki Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Noriaki Endo. A scholar is included among the top collaborators of Noriaki Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriaki Endo. Noriaki Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moree, Wilna J., Ken-ichiro Kataoka, Tatsuki Shiota, et al.. (2008). Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series. Bioorganic & Medicinal Chemistry Letters. 18(6). 1869–1873. 22 indexed citations
2.
Shiota, Tatsuki, Ken-ichiro Kataoka, Christine M. Tarby, et al.. (2004). Small molecule inhibitors of the CCR2b receptor. Part 1: Discovery and optimization of homopiperazine derivatives. Bioorganic & Medicinal Chemistry Letters. 14(21). 5407–5411. 22 indexed citations
3.
Moree, Wilna J., Ken-ichiro Kataoka, Tatsuki Shiota, et al.. (2004). Small molecule antagonists of the CCR2b receptor. Part 2: Discovery process and initial structure–activity relationships of diamine derivatives. Bioorganic & Medicinal Chemistry Letters. 14(21). 5413–5416. 33 indexed citations
4.
Tamura, Mizuho, et al.. (1999). Differential production of MCP-1 and cytokine-induced neutrophil chemoattractant in the ischemic brain after transient focal ischemia in rats. Journal of Leukocyte Biology. 65(6). 744–749. 120 indexed citations
5.
Tomiyama, Takami, Hideshi Kaneko, Ken-ichiro Kataoka, Satoshi Asano, & Noriaki Endo. (1997). Rifampicin inhibits the toxicity of pre-aggregated amyloid peptides by binding to peptide fibrils and preventing amyloid-cell interaction. Biochemical Journal. 322(3). 859–865. 78 indexed citations
6.
Tanaka, Hiroko, et al.. (1997). Monocyte chemoattractant protein‐2 can exert its effects through the MCP‐1 receptor (CC CKR2B). FEBS Letters. 400(3). 329–332. 22 indexed citations
7.
Tomiyama, Takami, Ken-ichiro Kataoka, Yorimasa Suwa, et al.. (1996). Inhibition of Amyloid β Protein Aggregation and Neurotoxicity by Rifampicin. Journal of Biological Chemistry. 271(12). 6839–6844. 251 indexed citations
8.
Tanaka, Hiroko, et al.. (1995). Full Active Baculovirus-Expressed Human Monocyte Chemoattractant Protein 1 with the Intact N-Terminus. Biochemical and Biophysical Research Communications. 206(3). 955–961. 15 indexed citations
9.
Tanaka, Hiroko, et al.. (1995). The effect of a synthetic 7‐thiaprostaglandin E1 derivative, TEI‐6122, on monocyte chemoattractant protein‐1 induced chemotaxis in THP‐1 cells. British Journal of Pharmacology. 116(4). 2298–2302. 5 indexed citations
10.
Tomiyama, Takami, Satoshi Asano, Yoshihiro Suwa, et al.. (1994). Rifampicin Prevents the Aggregation and Neurotoxicity of Amyloid β Protein in Vitro. Biochemical and Biophysical Research Communications. 204(1). 76–83. 136 indexed citations
11.
Tokuda, Yoshiyuki, et al.. (1994). cDNA Cloning and Functional Expression of a Human Monocyte Chemoattractant Protein 1 Receptor. Biochemical and Biophysical Research Communications. 202(2). 1156–1162. 31 indexed citations
12.
Tomiyama, Takami, Satoshi Asano, Yoshiko Furiya, et al.. (1994). Racemization of Asp23 residue affects the aggregation properties of Alzheimer amyloid beta protein analogues.. Journal of Biological Chemistry. 269(14). 10205–10208. 142 indexed citations
13.
Mori, Hiroshi, Kazuhiro Ishii, Takami Tomiyama, et al.. (1994). Racemization: Its Biological Significance on Neuropathogenesis of Alzheimer's Disease.. The Tohoku Journal of Experimental Medicine. 174(3). 251–262. 49 indexed citations
14.
Yago, Kazuhiro, K Zenita, Shiro Nozawa, et al.. (1993). Immunoglobulin variable region sequences of two human monoclonal antibodies directed to an onco-developmental carbohydrate antigen, lactotetraosylceramide (LcOse4 Cer). Molecular Immunology. 30(16). 1481–1489. 3 indexed citations
15.
Ohmori, Hitoshi, Naoki Hase, Masaki Hikida, Toshiyuki Takai, & Noriaki Endo. (1992). Enhancement of antigen-induced interleukin 4 and IgE production by specific IgG1 in murine lymphocytes. Cellular Immunology. 145(2). 299–310. 13 indexed citations
16.
Richardson, Jennifer, et al.. (1989). PCR Analysis of DNA from Multiple Sclerosis Patients for the Presence of HTLV-I. Science. 246(4931). 821–823. 3 indexed citations
17.
Endo, Noriaki, Yumiko Takeda, Naoji Umemoto, et al.. (1988). Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.. PubMed. 48(12). 3330–5. 26 indexed citations
18.
Endo, Noriaki, Naoji Umemoto, Yoshinori Katō, Yumiko Takeda, & Takeshi Hara. (1987). A novel covalent modification of antibodies at their amino groups with retention of antigen-binding activity. Journal of Immunological Methods. 104(1-2). 253–258. 32 indexed citations
19.
Endo, Noriaki, Yumiko Takeda, Kazuo Kishida, et al.. (1987). Target-selective cytotoxicity of methotrexate conjugated with monoclonal anti-MM46 antibody. Cancer Immunology Immunotherapy. 25(1). 1–6. 25 indexed citations
20.
Endo, Noriaki, Yoshinori Katō, Yumiko Takeda, et al.. (1987). In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.. PubMed. 47(4). 1076–80. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rodger A. Allen Breakdown of academic impact, for papers by Stefani N. Thomas Breakdown of academic impact, for papers by Peter Olofsson Breakdown of academic impact, for papers by Kaoru Saegusa Breakdown of academic impact, for papers by Heidi A. Zürcher-Neely Breakdown of academic impact, for papers by Richard D. Bagshaw Breakdown of academic impact, for papers by James R. Burke Breakdown of academic impact, for papers by Sunanda G. Dastidar Breakdown of academic impact, for papers by François G. Gervais Breakdown of academic impact, for papers by David J. Shuster
Rankless by CCL
2026